Kesimpta

Kesimpta Coupons & Discount Card – Guaranteed Prices from $9300.69

Kesimpta (ofatumumab) is a medication used to manage relapsing forms of multiple sclerosis (MS). It is a type of monoclonal antibody that works by targeting certain immune system cells. These cells, if left unchecked, may mistakenly attack the nerve coverings in the brain and spinal cord, leading to MS symptoms. While Kesimpta is not a cure for MS, it helps to reduce the frequency of relapses and may delay the progression of disability associated with the disease. Kesimpta is administered as an injection under the skin. Initially, it is given weekly for the first month, and then once a month thereafter. The medication is available in a Sensoready Pen, which some patients may find easier to use compared to pre-filled syringes. Common side effects include an increased risk of infections and localized pain or swelling at the injection site. As with any medication, it's important to discuss with your healthcare provider whether Kesimpta is suitable for you, considering your specific health needs and conditions.
Our Kesimpta coupons are free to use. You can print the coupon, email it to yourself, or receive the Kesimpta coupon via text message. To get your free discount, show the pharmacist your Kesimpta savings card which has the discounted coupon price. Use our filters below to edit the prescription box to match your needs. The Kesimpta prices will update based on your prescription needs. Above our Kesimpta coupons, you can change the location to see pharmacy prices in other areas. Our prescription discount card will update online with the specific pharmacy costs associated with your edits. Be sure to text, email, or print the Kesimpta savings card code that you need after editing the prescription box and location field. Show the discount card to your pharmacist before paying.

My prescription

Edit

0.4ML of 20MG/0.4ML, Kesimpta (1 Pen)

Select pharmacy

Pharmacy logo

Rite Aid

$9300.69

COUPON PRICE
Pharmacy logo

Walgreens

$9694.26

COUPON PRICE

Kesimpta savings card

Show this card to your pharmacist
Pharmacy logo

Rite Aid

$9300.69

BIN

ID

PCN

GRP

019876

LHC7F1A02B

CHIPPO

LHX

Powered by

This card is not insurance

Related monoclonal antibodies prescriptions

coupons from$1.01 
coupons from$5895.58Save 72%
coupons from$1.76Save 86%
coupons from$1319.88Save 72%
coupons from$2893.1Save 72%
coupons from$17377.12 
coupons from$1836.97Save 58%
coupons from$20385.13 

More prescriptions for multiple sclerosis

coupons from$9650.56Save 72%
coupons from$1741.56Save 72%
coupons from$2283.95Save 72%
coupons from$159.1Save 91%
coupons from$2518.57Save 72%
coupons from$1157.12Save 74%
coupons from$1847.78 
coupons from$16014.33Save 72%

Related monoclonal antibodies prescriptions

Evusheldcoupons from $1.01
Fasenra Save 72%coupons from $5895.58
Casirivimab Save 86%coupons from $1.76
Evenity Save 72%coupons from $1319.88
Siliq Save 72%coupons from $2893.1
Ilumyacoupons from $17377.12
Synagis Save 58%coupons from $1836.97
Ilariscoupons from $20385.13

More prescriptions for multiple sclerosis

Ponvory Save 72%coupons from $9650.56
Bafiertam Save 72%coupons from $1741.56
Vumerity Save 72%coupons from $2283.95
Baclofen Save 91%coupons from $159.1
Mayzent Save 72%coupons from $2518.57
Tecfidera Save 74%coupons from $1157.12
Rebifcoupons from $1847.78
Extavia Save 72%coupons from $16014.33

Kesimpta dosage forms

The average cost for 1 Pen of Kesimpta at 0.4ML of 20MG/0.4ML is $9038.4 with a free coupon. This is 68% off the average retail price of $28367.35
DosageQuantityPrice fromPer unit
0.4ML of 20MG/0.4ML1 Pen$9038.4$9038.4

Kesimpta Warnings

This document provides key safety information regarding the use of Kesimpta (ofatumumab). It is crucial to review the following points and discuss any concerns with your healthcare provider.

  • Increased Risk of Infections: Kesimpta (ofatumumab) may reduce your body's ability to combat infections, increasing the likelihood of bacterial, viral, or fungal infections. This risk is heightened if you are currently taking or have recently taken other medications that suppress the immune system. Additionally, Kesimpta (ofatumumab) can reactivate certain viruses, such as the hepatitis B virus (HBV), present in your body, which can be dangerous. If you develop an infection, your healthcare provider may advise discontinuing Kesimpta (ofatumumab) until the infection is resolved. This is particularly important for those with active or chronic infections, conditions that increase infection risk, or those on immunosuppressive drugs.

  • Injection Reactions: After taking Kesimpta (ofatumumab), you may experience reactions related to the injection, including fever, headache, muscle pain, chills, and fatigue. These reactions are more common within the first day of the initial dose but can occur with subsequent doses. To ensure your safety, your first injection should be administered in a hospital or clinic setting, where medical help is readily available in case of severe reactions.

  • Potential Harm to Unborn Babies: Animal studies suggest that Kesimpta (ofatumumab) may harm unborn babies; therefore, it is advised for females who are or could become pregnant to avoid using this medication. Use effective contraception during treatment and for at least six months following the last dose. If you are pregnant or planning to become pregnant, consult your healthcare provider to discuss safer alternatives for you and your baby.

Contraindications:

  • Do not use Kesimpta (ofatumumab) if you have an active hepatitis B infection, as this medication may pose serious health risks in such cases. Always speak to your healthcare provider if you have any concerns or questions regarding its use.

Kesimpta Side Effects

When using this medication, some individuals may experience common side effects, which are generally mild and include redness, swelling, itching, or pain at the injection site. You might also notice fever, headaches, muscle aches, chills, and general tiredness. These reactions often become milder with subsequent doses. If they persist or worsen, it is important to consult your healthcare provider. Sore throat, runny nose, and symptoms akin to respiratory tract infections can occur, as well as urinary tract infection symptoms like pain while urinating.

In rare instances, this medication can lead to more severe side effects. It may suppress your immune system, increasing the risk of serious infections characterized by a persistent sore throat, fever, chills, or cough. Additionally, it can cause liver disease, particularly for those with a history of hepatitis B, potentially leading to nausea, vomiting, loss of appetite, stomach pain, jaundice, or dark urine. There is also a rare risk of developing progressive multifocal leukoencephalopathy (PML), a serious brain infection. Symptoms include clumsiness, loss of coordination, confusion, memory loss, difficulty talking, seizures, and vision changes.

Severe allergic reactions are very rare but serious. Seek immediate medical assistance if you experience symptoms like a rash, swelling of the face or throat, severe dizziness, or trouble breathing. If you notice other side effects not mentioned here, contact your healthcare provider.

Kesimpta Interactions

Certain medications can interact with this drug, particularly those that suppress the immune system or heighten the risk of infection, like natalizumab and rituximab.
Kesimpta FAQs
What is Kesimpta medicine used for?

Kesimpta is used for the treatment of relapsing forms of multiple sclerosis (MS) in adults. This includes clinically isolated syndrome, relapsing-remitting disease, and active secondary progressive disease.

The duration a patient can stay on Kesimpta (ofatumumab) is determined by their healthcare provider based on the individual's response to the treatment and any side effects experienced. There is no specific maximum duration established, and treatment can continue as long as it remains effective and the patient tolerates it well. Regular monitoring and consultations with a healthcare provider are essential to assess the ongoing suitability of the medication.

The cost of Kesimpta can vary based on factors such as insurance coverage, location, and pharmacy. Without insurance, the list price for Kesimpta is approximately $6,900 per month, which totals around $82,800 annually. However, patients are encouraged to check with their insurance provider and explore patient assistance programs that may significantly reduce out-of-pocket expenses.

The choice between Kesimpta and Ocrevus depends on various factors, including the specific medical condition being treated, the patient's health profile, and their response to previous treatments. Both medications are used to treat multiple sclerosis, but they have different administration methods and dosing schedules. Kesimpta is administered as a subcutaneous injection, while Ocrevus is given as an intravenous infusion. The decision on which medication is better should be made by a healthcare provider, who can consider the patient's individual needs and preferences.

The duration a patient can stay on Kesimpta (ofatumumab) is determined by their healthcare provider based on the individual's response to the treatment and any side effects experienced. There is no specific maximum duration for using Kesimpta, and it can be continued as long as it remains effective and well-tolerated. Regular monitoring and consultations with a healthcare provider are essential to assess the ongoing suitability of the treatment.